Strategic Acquisition Biotech Dental was acquired by Henry Schein in 2023, signaling access to an expanded distribution network and potential integration opportunities for sales of implants, software, and aligners through a larger channel.

Digital Platform LaGalaxy platform launched to consolidate clinical and administrative tasks, presenting cross-sell opportunities for practice management solutions, data integration services, and cloud-enabled implant workflows.

3D Scanning Recent partnerships to develop highly accurate 3D intraoral scanners position Biotech Dental to offer or bundle advanced imaging tech with implants and software, enabling upsell to digital dentistry suites.

R&D Focus With significant investment in R&D (over 10 percent of turnover) and a track record of innovative solutions, there is potential to co-develop or white-label next-gen implants, tools, or software for current distribution partners.

Global Reach A global install base with over 2 million implants sold and a broad product range creates opportunities for multi-product deals, bundled offerings, and cross-selling across allied dental specialties through existing networks.